Analysis for MET
- 📈 Growth — 22/30
- 💰 Profitability — 14/20
- 🏦 Financial Health — 9/20
- 💵 Valuation — 10/20
- ⚠️ Risk — 4/10
Summary:
📈 Growth & Financial Trajectory
Over the eight quarters, METLIFE shows a generally flat revenue base around the high teens to low 20s billions, with a notable spike in 2025 Q4 to about $23.8B before easing to $19.1B in 2026 Q1. Net income progressed from about $0.61B in 2023 Q4 to $1.16B in 2026 Q1, reflecting improving profitability despite revenue volatility. The end-to-start revenue is roughly flat (+1%), while trailing twelve months show a meaningful uplift in earnings power, aided by better cost control in several quarters. The trajectory favors a modestly positive growth view, albeit with risk around seasonality and one-off timing in Q4 2025.
💰 Margins & Cash Flow
Gross margin across quarters averages around the mid-single digits, roughly 6–8%, with operating margin generally in the 6–9% range; the high level of benefits and reserves typical of a life insurer weigh on margin but operating income remains positive. Cash flow from operations is solid, with quarterly operating cash flow often in the billions, while investing cash flow is irregular (outsized negative in some periods) and financing cash flow more volatile, reflecting pension and capital actions. Net cash flow trends align with the reported earnings, showing resilience despite quarterly swings.
🛡️ Balance Sheet & Liquidity
Assets and current assets sit near the $0.68–0.75T range, with current liabilities similarly large. Equity remains modest relative to liabilities, a typical profile for large insurers with long-duration reserves. Liquidity appears adequate to support operating needs, though the balance sheet remains highly leveraged in aggregate terms due to liabilities.
⚠️ Key Drivers & Risks
- Drivers: Insurer premium revenue cycles, macroeconomic interest-rate environment, and capital deployment
- Risks: Regulatory cyclicality, reserve adequacy, and sensitivity to large one-off quarterly moves